237 related articles for article (PubMed ID: 18418022)
1. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
Calvo-Villas JM; Urcuyo BM; Umpierrez AM; Sicilia F
Onkologie; 2008 Apr; 31(4):197-9. PubMed ID: 18418022
[TBL] [Abstract][Full Text] [Related]
2. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
3. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
4. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
5. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Ramachandran A; Majumdar G
Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
8. Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy.
Nakazawa H; Nishina S; Mimura Y; Kawakami T; Senoo Y; Sakai K; Nakazawa K; Kitano K
Int J Hematol; 2014 Jun; 99(6):782-5. PubMed ID: 24584911
[TBL] [Abstract][Full Text] [Related]
9. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
Montalban C; Liaño F; Aguilera A
Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
[TBL] [Abstract][Full Text] [Related]
10. Oral fludarabine.
Plosker GL; Figgitt DP
Drugs; 2003; 63(21):2317-23. PubMed ID: 14524733
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
Mulligan SP; Dean MG
Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
[No Abstract] [Full Text] [Related]
12. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
Frame JN; Dahut WL; Crowley S
N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
[No Abstract] [Full Text] [Related]
13. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.
Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K
Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.
Bergmann L; Fenchel K; Jahn B; Mitrou PS; Hoelzer D
Ann Oncol; 1993 May; 4(5):371-5. PubMed ID: 8353071
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
19. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
20. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.
Cheson BD; Heitner Enschede S; Cerri E; Desai M; Potluri J; Lamanna N; Tam C
Oncologist; 2017 Nov; 22(11):1283-1291. PubMed ID: 28851760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
